The relevance of these findings was supported by an inverse correlation between miR-26a and E2F7 in ERα+ breast cancer64 and by the correlation between E2F7 levels, the risk of relapse, and the poor prognosis in breast cancer patients treated with tamoxifen.63 The gene discussed is ESR1; the disease is breast carcinoma.